Although carriers of MSH6 germline mutations, who exhibit a lower amount of MMR-D adenomas, had a great incidence of adenomas, patients with MSH2 and MLH1 germline mutations showed the highest risk of early CRC onset [36,49,51] (Supplementary Table S1). This evidence concerns the gene MSH6 and adenoma.